Self-Management of Blood Pressure in Resistant Hypertension
ConditionResistant Hypertension
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTaichung Veterans General Hospital
About this trial
The trial is a 12-month randomized, parallel-group study comparing three arms: (1) HBP self-management with AI chatbot support, (2) HBP self-management without AI chatbot support, and (3) usual care. The primary objective is to evaluate differences in blood pressure changes and medication compliance between groups at 6 and 12 months.
Eligibility criteria
Qualifiers
≥18 years of age
receiving ≥3 antihypertensive medications of different classes, including a diuretic, and baseline BP >130/80 mmHg; or receiving ≥ 4 medications regardless of BP
Disqualifiers
unable to conduct self-monitor BP because of cognitive dysfunction
poor adherence to medication
poor digital capabilities
pregnant
Trial design
Treatments tested in this trial
- AI chatbot support
- telemonitoring and case management
Treatment groups
600 Participants
are divided into 3 treatment groupsLocations
5Kaohsiung Medical University Chung-Ho Memorial Hospital807, Kaohsiung City Taiwan
Kaohsiung Veterans General Hospital813414, Kaohsiung City Taiwan
Taichung Veterans General Hospital407, Taichung Taiwan
National Taiwan University Hospital100, Taipei Taiwan
Sponsors and collaborators
Taichung Veterans General Hospital
Lead sponsor
Source ClinicalTrials.gov